Sign in Subscribe
Class action lawsuits

Sarepta Investors File Class Action Lawsuit over Alleged Securities Fraud

Strategic Insights

— 1 min read

Sarepta Therapeutics, Inc.'s investors who bought the company's stock between June 22, 2023, and June 24, 2025, may be eligible to join a class action securities lawsuit. The lawsuit claims that the company and its executives made false statements or concealed the risks associated with ELEVIDYS, a prescription gene therapy for Duchenne. This alleged securities fraud allegedly misled investors about the therapy's safety risks, trial protocols, and regulatory scrutiny.

Key Takeaways:

  • The lawsuit targets Sarepta Therapeutics, Inc. and its executives over alleged securities fraud.
  • The lawsuit claims that the company made false statements about ELEVIDYS' safety risks, trial protocols, and regulatory scrutiny.
  • The lawsuit covers investors who bought Sarepta stock between June 22, 2023, and June 24, 2025.
  • Investors have until August 25, 2025, to request that the Court appoint them as lead plaintiff.
  • Participating in the lawsuit requires no payment of out-of-pocket costs or fees.
  • Levi & Korsinsky, LLP is representing the investors in this case.
  • The firm has a 20-year track record of securing hundreds of millions of dollars for aggrieved shareholders.
  • Levi & Korsinsky, LLP has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States for seven consecutive years.

Statistics:

  • The lawsuit covers Sarepta investors who bought the company's stock between June 22, 2023, and June 24, 2025.
  • Investors have until August 25, 2025, to request that the Court appoint them as lead plaintiff.
  • Levi & Korsinsky, LLP has saved its clients over $300 million in the past.
  • The team at Levi & Korsinsky has over 70 employees serving their clients.
  • The firm has won high-stakes cases for seven years in a row.

Sources:

  • Sarepta investors may contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Sarepta investors who were adversely affected by alleged securities fraud between June 22, 2023, and June 24, 2025.

Read more